Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer

Biochemical and Biophysical Research Communications

Volumn 456, Issue 1, 2015, Pages 183-189

  Fujii, Tomomi ^a   Shimada, Keiji ^a   Tatsumi, Yoshihiro ^a   Fujimoto, Kiyohide ^a   Konishi, Noboru ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

MicroRNA; MiR 126; MiR 149; Prostate cancer; Syndecan 1

Indexed keywords

BETA GALACTOSIDASE; MICRORNA; MICRORNA 126; MICRORNA 149; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P21; SYNDECAN 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HOMEODOMAIN PROTEIN; MESSENGER RNA; MIRN126 MICRORNA, HUMAN; MIRN149 MICRORNA, HUMAN; NANOG PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; SDC1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LNCAP CELL LINE; MALE; MTS ASSAY; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; CELL AGING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

BETA-GALACTOSIDASE; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-3; PROSTATIC NEOPLASMS; RNA, MESSENGER; SOXB1 TRANSCRIPTION FACTORS; SYNDECAN-1; TRANSFECTION;

EID: 84919665823     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.056     Document Type: Article

References (42)

1. R. Garzon, M. Fabbri, and A. Cimmino MicroRNA expression and function in cancer Trends Mol. Med. 12 2006 580 587
2. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
3. B.P. Lewis, I.H. Shih, and M.W. Jones-Rhoades Prediction of mammalian microRNA targets Cell 115 2003 787 798
4. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
5. K. Kojima, Y. Fujita, and Y. Nozawa MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms Prostate 70 2010 1501 1512
6. Y. Fujita, K. Kojima, and N. Hamada Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells Biochem. Biophys. Res. Commun. 377 2008 114 119
7. C. Liu, K. Kelnar, and B. Liu The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Nat. Med. 17 2011 211 215
8. Y. Fujita, K. Kojima, and R. Ohhashi MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression J. Biol. Chem. 285 2010 19076 19084
9. S. Galardi, N. Mercatelli, and M.G. Farace NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells Nucleic Acids Res. 39 2011 3892 3902
10. S. Galardi, N. Mercatelli, and E. Giorda MiR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 J. Biol. Chem. 282 2007 23716 23724
11. S. Huang, W. Guo, and Y. Tang MiR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells Oncol. Rep. 28 2012 1831 1837
12. B. Xu, X. Niu, and X. Zhang MiR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS Mol. Cell. Biochem. 350 2011 207 213
13. H.L. Zhang, L.F. Yang, and Y. Zhu Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy Prostate 71 2011 326 331
14. S. Sheth, S. Jajoo, and T. Kaur Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway PLoS ONE 7 2012 e51655
15. G.H. Shi, D.W. Ye, and X.D. Yao Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells Acta Pharmacol. Sin. 31 2010 867 873
16. T. Li, D. Li, and J. Sha MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells Biochem. Biophys. Res. Commun. 383 2009 280 285
17. M.R. Epis, A. Barker, and K.M. Giles The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells J. Biol. Chem. 286 2011 41442 41454
18. U. Lehmann, B. Hasemeier, and M. Christgen Epigenetic inactivation of microRNA gene hsa-miR-9-1 in human breast cancer J. Pathol. 214 2008 17 24
19. T. Katada, H. Ishiguro, and Y. Kuwabara MicroRNA expression profile in undifferentiated gastric cancer Int. J. Oncol. 34 2009 537 542
20. M. Bernfield, M. Götte, and P.W. Park Functions of cell surface heparan sulfate proteoglycans Annu. Rev. Biochem. 68 1999 729 777
21. F.P. O'Connell, J.L. Pinkus, and G.S. Pinkus CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms Am. J. Clin. Pathol. 121 2004 254 263
22. K. Shimada, and M. Nakamura Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer Cancer Sci. 100 2009 1248 1254
23. J. Kiviniemi, M. Kallajoki, and I. Kujala Altered expression of syndecan-1 in prostate cancer APMIS 112 2004 89 97
24. T. Otsubo, Y. Akiyama, and Y. Hashimoto MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis PLoS ONE 6 2011 e16617
25. J. Mathieu, Z. Zhang, and W. Zhou HIF induces human embryonic stem cell markers in cancer cells Cancer Res. 71 2011 4640 4652
26. M. Crawford, E. Brawner, and K. Batte MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines Biochem. Biophys. Res. Commun. 373 2008 607 612
27. J. Yang, H. Lan, and X. Huang MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients PLoS ONE 7 2012 e42978
28. T. Sasahira, M. Kurihara, and U.K. Bhawal Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer Br. J. Cancer 107 2012 700 706
29. T.F. Hansen, C.L. Andersen, and B.S. Nielsen Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer Oncol. Lett. 2 2011 1101 1106
30. A. Watahiki, Y. Wang, J. Morris, K. Dennis, H.M. O'Dwyer, M. Gleave, P.W. Gout, and Y. Wang MicroRNAs associated with metastatic prostate cancer PLoS ONE 6 2011 e24950
31. K. Shimada, S. Anai, and D.A. Marco Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival BMC Urol. 11 2011 8
32. D. Chen, B. Adenekan, and L. Chen Syndecan-1 expression in locally invasive and metastatic prostate cancer Urology 63 2004 402 407
33. M.J. Stanley, M.W. Stanley, and R.D. Sanderson Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma Am. J. Clin. Pathol. 112 1999 377 383
34. J.P. Wiksten, J. Lundin, and S. Nordling A prognostic value of syndecan-1 in gastric cancer Anticancer Res. 20 2000 4905 4907
35. A. Anttonen, M. Kajanti, and P. Heikkilä Syndecan-1 expression has prognostic significance in head and neck carcinoma Br. J. Cancer 79 1999 558 564
36. K. Shimada, S. Anai, and T. Fujii Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells J. Pathol. 231 2013 495 504
37. S. Wang, A.B. Aurora, and B.A. Johnson The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Dev. Cell 15 2008 261 271
38. J.E. Fish, M.M. Santoro, and S.U. Morton MiR-126 regulates angiogenic signaling and vascular integrity Dev. Cell 15 2008 272 284
39. S. Nicoli, C. Standley, and P. Walker MicroRNA-mediated integration of haemodynamics and VEGF signalling during angiogenesis Nature 464 2010 1196 1200
40. C. Guo, J.F. Sah, and L. Beard The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers Genes Chromosomes Cancer 47 2008 939 946
41. J. Zhang, Y.Y. Du, and Y.F. Lin The cell growth suppressor, miR-126, targets IRS-1 Biochem. Biophys. Res. Commun. 377 2008 136 140
42. Z. Luo, L. Zhang, and Z. Li An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma BMC Med. Genomics 5 2012 3